News
10-05-2013, 12:10 AM
Amgen today announced that it will present data from several romosozumab and Prolia® (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013.
More... (http://www.news-medical.net/news/20131005/Amgen-presents-data-from-several-romosozumab-and-Prolia-at-ASBMR-2013-Annual-Meeting.aspx)
More... (http://www.news-medical.net/news/20131005/Amgen-presents-data-from-several-romosozumab-and-Prolia-at-ASBMR-2013-Annual-Meeting.aspx)